Abeona Therapeutics
ABEO
58 hedge funds and large institutions have $71.6M invested in Abeona Therapeutics in 2017 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 7 closing their positions.
100% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 7
28% more call options, than puts
Call options by funds: $132K | Put options by funds: $103K
15% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 13
7% more funds holding
Funds holding: 54 → 58 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.05% less ownership
Funds ownership: 1.49% → 1.43% (-0.05%)
1% less capital invested
Capital invested by funds: $72M → $71.6M (-$459K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CHP
Castle Hook Partners
New York
|
+$1.88M |
| 2 |
JGC
J. Goldman & Co
New York
|
+$1.47M |
| 3 |
BlackRock
New York
|
+$1.33M |
| 4 |
HCM
Highbridge Capital Management
New York
|
+$670K |
| 5 |
Goldman Sachs
New York
|
+$537K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$5.54M |
| 2 |
PA
Perceptive Advisors
New York
|
-$1.13M |
| 3 |
Jennison Associates
New York
|
-$686K |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$645K |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$516K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AG
51
Advisor Group
Phoenix,
Arizona
| $3K | – | – | – |
|
|
TRCT
52
Tower Research Capital (TRC)
New York
| $2K | -$11K | -85 | -81% |
|
53
Bank of America
Charlotte,
North Carolina
| $1K | -$516 | -4 | -33% |
|
54
Citigroup
New York
| $1K | – | – | – |
|
55
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $1K | – | – | – |
|
56
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $1K | – | – | – |
|
|
MTIP
57
Magee Thomson Investment Partners
San Diego,
California
| $1K | +$645 | +5 | New |
|
|
RCM
58
RA Capital Management
Boston,
Massachusetts
| – | -$5.54M | -45,714 | Closed |
|
|
59
Jennison Associates
New York
| – | -$686K | -5,656 | Closed |
|
|
VKH
60
Virtu KCG Holdings
New York
| – | -$136K | -1,124 | Closed |
|
|
JG
61
Jefferies Group
New York
| – | -$121K | -1,000 | Closed |
|
|
ARTA
62
A.R.T. Advisors
New York
| – | -$117K | -968 | Closed |
|
63
Citadel Advisors
Miami,
Florida
| – | -$79K | -654 | Closed |
|
|
AIM
64
Acrospire Investment Management
Chicago,
Illinois
| – | -$47K | -391 | Closed |
|
65
Simplex Trading
Chicago,
Illinois
| – | +$516 | +4 | New |
|
ABEO Hedge Fund Activity: Q1 2017 in Review
58 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q1 2017, worth a combined $71.6M — down 0.64% from $72M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new ABEO positions and 7 closed out — a net gain of 7 holders — while 15 added to existing stakes and 13 trimmed.
The largest buyer was Castle Hook Partners, adding an estimated $1.88M. The largest seller was RA Capital Management, exiting entirely with an estimated $5.54M sold.
- 58 institutional investors held Abeona Therapeutics (ABEO) as of Q1 2017, up from 54 in Q4 2016.
- Funds reported $71.6M of Abeona Therapeutics stock for Q1 2017, down 0.64% quarter-over-quarter.
- 14 funds opened new Abeona Therapeutics positions in Q1 2017 and 7 closed out, a net change of +7 holders.
- The largest Abeona Therapeutics buyer in Q1 2017 was Castle Hook Partners, an estimated $1.88M added.
- The largest Abeona Therapeutics seller in Q1 2017 was RA Capital Management, an estimated $5.54M sold.
Based on aggregated 13F filings for Q1 2017.